Around 18% of our revenue is allocated to research and development.
As a pharmaceutical company, PHARMAQ is subject to very stringent demands, regulated in the principles and guidance of Good Manufacturing Practice (GMP). PHARMAQ’s manufacturing facility in Overhalla, Norway is, on a regular basis, -approved according to GMP by the Norwegian Medicines Agency (NoMA).
Our subsidiary PHARMAQ Ltd. in UK has a registered pharmacy on our premises.
We hold a Manufacturer's Authorisation (ManA 11003) for our GMP compliant facility.
We hold a Wholesale Dealer's licence (WDA11003) and a Wholesale Dealer's Import licence.
We have an in-house pharmacy (Registration no.1031717).
We have Investors in People accreditation.
Awards and Honours
PHARMAQ is voted the best animal health company in Europe in 2015 by Animal Pharm
Credit Score Diploma 24-01-2013 by Experian Credit Services
The Credit Rating is a conclusion on a comapany`s creditworthiness and is based on all accessible information on the company and key staff, given by Experian 26 August 2010.
PHARMAQ won the prestigious Internationalisation price 2009 announced during an arrangement in Oslo Concert Hall on the evening of 18 November. The price was given by Innovation Norway.
PHARMAQ received an award from Great Place to Work Institute in March 2009. We can be very proud that we are among the top ten “Great Place to Work” companies in Norway.